Dana M. Jensen
YOU?
Author Swipe
View article: Comprehensive benchmarking of somatic single-nucleotide variant and indel detection at ultra-low allele fractions using short- and long-read data
Comprehensive benchmarking of somatic single-nucleotide variant and indel detection at ultra-low allele fractions using short- and long-read data Open
Mosaic mutations in normal tissues occur at low variant allele fractions (VAFs), complicating detection. To benchmark strategies, the SMaHT Network created a cell-line mixture (1:49) and produced ultra-deep whole-genome sequencing using sh…
View article: A telomere-to-telomere map of somatic mutation burden and functional impact in cancer
A telomere-to-telomere map of somatic mutation burden and functional impact in cancer Open
Oncogenesis involves widespread genetic and epigenetic alterations, yet the full spectrum of somatic variation genome-wide remains unresolved. We generated a near-telomere-to-telomere (T2T) diploid assembly of a donor paired with deep shor…
View article: Mosaic X-linked adrenoleukodystrophy in males identified by newborn screening and next-generation sequencing
Mosaic X-linked adrenoleukodystrophy in males identified by newborn screening and next-generation sequencing Open
View article: P014: Multiple cases of mosaic X-linked adrenoleukodystrophy in males identified through newborn screening
P014: Multiple cases of mosaic X-linked adrenoleukodystrophy in males identified through newborn screening Open
X-linked adrenoleukodystrophy (X-ALD) is a metabolic disorder affecting ∼1:15000 individuals. X-ALD is caused by variants in ABCD1 (located at Xq28), which encodes an ATP-binding cassette and is responsible for importing very long chain fa…
View article: Upregulated MicroRNA-21 Drives the Proliferation of Lymphatic Malformation Endothelial Cells by Inhibiting PDCD4
Upregulated MicroRNA-21 Drives the Proliferation of Lymphatic Malformation Endothelial Cells by Inhibiting PDCD4 Open
View article: Primary targeted medical therapy for management of bilateral head and neck lymphatic malformations in infants
Primary targeted medical therapy for management of bilateral head and neck lymphatic malformations in infants Open
View article: Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth
Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth Open
View article: Somatic activating BRAF variants cause isolated lymphatic malformations
Somatic activating BRAF variants cause isolated lymphatic malformations Open
Somatic activating variants in PIK3CA, the gene that encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3K), have been previously detected in ∼80% of lymphatic malformations (LMs).1 ,
View article: eP282: Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth
eP282: Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth Open
View article: Cerebrofacial vascular metameric syndrome is caused by somatic pathogenic variants in <i>PIK3CA</i>
Cerebrofacial vascular metameric syndrome is caused by somatic pathogenic variants in <i>PIK3CA</i> Open
Disorganized morphogenesis of arteries, veins, capillaries, and lymphatic vessels results in vascular malformations. Most individuals with isolated vascular malformations have postzygotic (mosaic), activating pathogenic variants in a handf…
View article: Somatic activating <i>BRAF</i> variants cause isolated lymphatic malformations
Somatic activating <i>BRAF</i> variants cause isolated lymphatic malformations Open
Somatic activating variants in PIK3CA , the gene that encodes the p110 α catalytic subunit of PI3K, have been previously detected in ∼80% of lymphatic malformations (LM). 1; 2 We report the presence of somatic activating variants in BRAF i…
View article: Acetylsalicylic acid suppression of the PI3K pathway as a novel medical therapy for head and neck lymphatic malformations
Acetylsalicylic acid suppression of the PI3K pathway as a novel medical therapy for head and neck lymphatic malformations Open
View article: Cell-free DNA as a diagnostic analyte for molecular diagnosis of vascular malformations
Cell-free DNA as a diagnostic analyte for molecular diagnosis of vascular malformations Open
View article: Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformations
Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformations Open
Lymphatic malformations (LMs) are congenital, nonneoplastic vascular malformations associated with postzygotic activating PIK3CA mutations. The mutation spectrum within LMs is narrow, with the majority having 1 of 3 hotspot mutations. Desp…
View article: Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia
Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia Open
Bi-allelic loss-of-function variants in genes that encode subunits of the adaptor protein complex 4 (AP-4) lead to prototypical yet poorly understood forms of childhood-onset and complex hereditary spastic paraplegia: SPG47 (AP4B1), SPG50 …
View article: Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia
Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia Open
View article: Characterization of a severe case of <i>PIK3CA</i>‐related overgrowth at autopsy by droplet digital polymerase chain reaction and report of <i>PIK3CA</i> sequencing in 22 patients
Characterization of a severe case of <i>PIK3CA</i>‐related overgrowth at autopsy by droplet digital polymerase chain reaction and report of <i>PIK3CA</i> sequencing in 22 patients Open
PIK3CA ‐related overgrowth spectrum (PROS) refers to a group of disorders of segmental overgrowth of a wide variety of tissues as well as venous and lymphatic malformations. Clinical and molecular diagnosis can be challenging due to phenot…
View article: Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis
Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis Open